https://www.selleckchem.com/pr....oducts/brigatinib-ap
52 (2.24-18.95) compared with those without elevation in any of 4 biomarkers. The simultaneous inclusion of all 4 biomarkers to the conventional model significantly improved discrimination (C statistic increased from 0.702 to 0.748, P=0.004) and risk reclassification (net reclassification improvement 45.0%; integrated discrimination improvement 6.2%; both P0.001) for depression after stroke. We selected biomarkers that had previously been reported to be promising predictors of depression after stroke, while other novel bi
Like
Comment
Share
